SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-09-035867
Filing Date
2009-05-29
Accepted
2009-05-29 17:02:43
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 a09-14485_1s3.htm S-3 366384
2 EX-4.3 a09-14485_1ex4d3.htm EX-4.3 50576
3 EX-5.1 a09-14485_1ex5d1.htm EX-5.1 26570
4 EX-23.1 a09-14485_1ex23d1.htm EX-23.1 2929
5 GRAPHIC g144851cei001.jpg GRAPHIC 4395
6 GRAPHIC g144852kc01i001.jpg GRAPHIC 5342
7 GRAPHIC g144851bei001.jpg GRAPHIC 4395
8 GRAPHIC g144852kc03i001.jpg GRAPHIC 1451
  Complete submission text file 0001104659-09-035867.txt   470022
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-159606 | Film No.: 09862567
SIC: 2836 Biological Products, (No Diagnostic Substances)